WASATCH ADVISORS LP – Denali Therapeutics Inc. Transaction History
WASATCH ADVISORS LP portfolio value:
$11.03M
portfolio value
WASATCH ADVISORS LP quarter portfolio value change:
+4.28%
quarter
Denali Therapeutics Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +5.21% | 17.79K shares | 977K | $30.69 | 359.47K |
Q2 2022 | share | Increase | +43.91% | 104.25K shares | 2.41M | $29.43 | 341.67K |
Q1 2022 | share | Increase | +36.26% | 63.18K shares | -133K | $32.17 | 237.42K |
Q4 2021 | share | Decrease | -0.16% | -286 shares | -1.03M | $45.05 | 174.24K |
Q3 2021 | share | Decrease | -67.51% | -362.71K shares | -33.33M | $50.45 | 174.52K |
Q2 2021 | share | Increase | +12.29% | 58.80K shares | 14.82M | $78.44 | 537.24K |
Q1 2021 | share | Decrease | -0.59% | -2.84K shares | -12.99M | $57.1 | 478.44K |
Q4 2020 | share | Decrease | -63.95% | -853.90K shares | -7.52M | $83.76 | 481.28K |
Q3 2020 | share | Increase | +10.95% | 131.77K shares | 18.74M | $35.83 | 1.33M |
Q2 2020 | share | Increase | +5.54% | 63.15K shares | 9.13M | $24.18 | 1.20M |
Q1 2020 | share | Increase | +7.89% | 83.41K shares | 1.55M | $17.51 | 1.14M |
Q4 2019 | share | Increase | +8.10% | 79.18K shares | 3.43M | $17.42 | 1.05M |
Q3 2019 | share | Decrease | -1.86% | -18.48K shares | -5.70M | $15.32 | 977.66K |
Q2 2019 | share | Increase | +21.35% | 175.24K shares | 1.61M | $20.76 | 996.14K |
Q1 2019 | share | Increase | +1702.36% | 775.35K shares | 18.12M | $23.22 | 820.90K |
Q4 2018 | share | Decrease | -23.15% | -13.72K shares | -348K | $20.66 | 45.54K |
Q3 2018 | share | Increase | +90.39% | 28.13K shares | 814K | $21.74 | 59.26K |
Q2 2018 | share | 0.00% | 0 shares | -138K | $15.25 | 31.13K | |
Q1 2018 | share | 0.00% | 0 shares | 126K | $19.69 | 31.13K | |
Q4 2017 | share | Increase | 0.00% | 31.13K shares | 487K | $15.64 | 31.13K |